Northwestern Medicine
Locations
Transplant Summary
Overview
The National Cancer Institute (NCI) has designated Lurie Cancer Center as one of only 57 Comprehensive Cancer Centers in the nation recognized for their “scientific leadership, resources, and the depth and breadth of their research."
Lurie Cancer Center is a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 32 of the world’s leading cancer centers devoted to defining and advancing high-quality, high-value cancer care.This center has been performing allogeneic transplants since 1991 and has been an NMDP transplant center since September 2001.
Attending physicians
Adult - Kehinde Adekola, George Georges, Leo Gordon, Adam Lin, Jayesh Mehta, Jonathan Moreira, Seema Singhal, Jane WinterTransplants performed
Marrow/PBSC and double cordCord blood transplants
Adult onlyOther programs and services
NM provides discounted rates at area hotels. We participate in several programs with the American Cancer Society and the Lurie Cancer Center for support and financial Assistance.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 280 patients.The actual 1-year survival of these patients is 69.6%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 67.7% and 77.6%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
640
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow0PBSC73Cord blood0Total73Unrelated donorMarrow0PBSC131Cord blood3Total134Total allogeneicMarrow0PBSC204Cord blood3Total207AutologousMarrowBoth marrow & PBSC 433PBSC—Cord blood—Total433Total combinedMarrowBoth marrow & PBSC 637PBSC—Cord blood3Total640All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-441845-643865+17Total73Unrelated 0-18019-442145-647065+43Total134Autologous 0-18019-444645-6421865+169Total433Total 0-18019-448545-6432665+229Total640Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
Northwestern Medicine and Robert H Lurie Comp Cancer Center Survivorship Program
675 N Saint Clair, Suite 2100 Chicago, IL 60611 Phone:312-695-0990 For more information about this program: https://www.cancer.northwestern.edu/cancer-care/survivorship/index.html (Opens in a new tab)Staff
Program Director:Sheetal Kircher, MDProgram Coordinator:Karen Kinahan, DNPMedical Specialties in Program
Allergy/immunology, cardiology, complementary and alternative medicine, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 90 days after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital